%0 Case Reports
%T Alemtuzumab-induced petechiae and epistaxis in a patient with relapsing-remitting multiple sclerosis: A case report.
%A Mahmoudi F
%A Emami SA
%A Masaeli F
%A Rayatpisheh N
%J Clin Case Rep
%V 11
%N 11
%D 2023 Nov
%M 38028047
暂无%R 10.1002/ccr3.8143
%X Here, we present a case of relapsing-remitting multiple sclerosis that experienced petechiae and epistaxis following treatment with second dose of alemtuzumab. This study highlights such effects, emphasizing the need for vigilance as alemtuzumab usage increases. Timely recognition and management are vital for patient care.